SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4ads'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 5	THR G 86 THR G 193 THR G 149 HIS G 21	None	1.33A	1d4fB-4adsG: 3.0	1d4fB-4adsG: 17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FOH_C_IPHC802_0 (PHENOL HYDROXYLASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	ASP G 45 GLY G 46 VAL G 213 ILE G 4 GLY G 7	None	1.39A	1fohC-4adsG: undetectable	1fohC-4adsG: 13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FOH_D_IPHD802_0 (PHENOL HYDROXYLASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	ASP G 45 GLY G 46 VAL G 213 ILE G 4 GLY G 7	None	1.36A	1fohD-4adsG: undetectable	1fohD-4adsG: 13.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L2I_A_CCSA417_0 (ESTROGEN RECEPTOR)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	3 / 3	GLU A 92 LYS A 84 VAL A 85	None	0.98A	1l2iA-4adsA: undetectable	1l2iA-4adsA: 23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MRG_A_ADNA300_1 (ALPHA-MOMORCHARIN)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 9	ILE A 25 PHE A 213 GLY A 234 ILE A 43 ALA A 42	None	1.17A	1mrgA-4adsA: undetectable	1mrgA-4adsA: 22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PN0_B_IPHB6022_0 (PHENOL 2-MONOOXYGENASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	ASP G 45 GLY G 46 VAL G 213 ILE G 4 GLY G 7	None	1.42A	1pn0B-4adsG: undetectable	1pn0B-4adsG: 14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PN0_C_IPHC6032_0 (PHENOL 2-MONOOXYGENASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	ASP G 45 GLY G 46 VAL G 213 ILE G 4 GLY G 7	None	1.41A	1pn0C-4adsG: undetectable	1pn0C-4adsG: 14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PN0_D_IPHD6042_0 (PHENOL 2-MONOOXYGENASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	ASP G 45 GLY G 46 VAL G 213 ILE G 4 GLY G 7	None	1.41A	1pn0D-4adsG: undetectable	1pn0D-4adsG: 14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T46_A_STIA3_2 (HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 7	VAL G 97 CYH G 152 ARG G 58 CYH G 87	None	1.19A	1t46A-4adsG: undetectable	1t46A-4adsG: 23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YA4_C_CTXC3_1 (CES1 PROTEIN)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	6 / 12	PHE G 209 GLY G 85 GLY G 89 VAL G 57 LEU G 92 LEU G 11	None	1.50A	1ya4C-4adsG: undetectable	1ya4C-4adsG: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOI_C_FRDC305_1 (POL POLYPROTEIN PEPTIDE INHIBITOR)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 5	GLY A 136 PRO A 209 VAL A 210 ILE A 149	None	0.85A	2aoiA-4adsA: undetectable	2aoiA-4adsA: 17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2UXO_B_TACB1211_1 (HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 11	LEU G 11 LEU G 68 ILE G 32 VAL G 48 ILE G 49	None	1.06A	2uxoB-4adsG: undetectable	2uxoB-4adsG: 20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZMA_A_ACAA501_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 8	ALA G 183 ILE G 181 ILE G 158 TYR G 157	None	1.05A	2zmaA-4adsG: undetectable	2zmaA-4adsG: 19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CL9_A_MTXA602_1 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE (DHFR-TS))	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 12	ALA A 214 ILE A 160 THR A 220 LEU A 267 PRO A 264	None	1.29A	3cl9A-4adsA: undetectable	3cl9A-4adsA: 20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 5	LEU A 104 GLN A 94 LEU A 96 GLU A 97	None	1.05A	3h5gA-4adsA: undetectable 3h5gB-4adsA: undetectable	3h5gA-4adsA: 7.89 3h5gB-4adsA: 7.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MDV_A_CL6A506_1 (CHOLESTEROL 24-HYDROXYLASE)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 9	LEU G 135 LEU G 169 ALA G 204 ALA G 184 THR G 193	None	1.13A	3mdvA-4adsG: undetectable	3mdvA-4adsG: 19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PHN_A_ACTA108_0 (PROTEIN P-30)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	3 / 3	THR G 55 SER G 54 ARG G 121	None	0.82A	3phnA-4adsG: undetectable	3phnA-4adsG: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AX8_A_SAMA1474_0 (WBDD)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	6 / 12	GLY A 217 ALA A 155 ILE A 218 ILE A 160 HIS A 166 ILE A 164	PO4 A 302 (-3.8A) PO4 A 302 ( 4.1A) None None None None	1.49A	4ax8A-4adsA: undetectable	4ax8A-4adsA: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZV_A_SAMA1474_0 (WBDD)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	6 / 12	GLY A 217 ALA A 155 ILE A 218 ILE A 160 HIS A 166 ILE A 164	PO4 A 302 (-3.8A) PO4 A 302 ( 4.1A) None None None None	1.49A	4azvA-4adsA: undetectable	4azvA-4adsA: 22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_C_CLQC303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 8	GLY G 7 VAL G 8 PHE G 75 ILE G 83	None	0.86A	4fglD-4adsG: 4.3	4fglD-4adsG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_D_CLQD303_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 7	GLY G 7 VAL G 8 PHE G 75 ILE G 83	None	0.87A	4fglC-4adsG: 4.2	4fglC-4adsG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYT_A_OBNA1104_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 12	GLU G 16 GLY G 51 ALA G 88 LEU G 11 THR G 56	None	1.12A	4hytA-4adsG: undetectable	4hytA-4adsG: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HYT_C_OBNC2004_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 12	GLU G 16 GLY G 51 ALA G 88 LEU G 11 THR G 56	None	1.13A	4hytC-4adsG: undetectable	4hytC-4adsG: 12.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOE_F_TR6F101_1 (DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT B E-SITE DNA2)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 6	SER A 107 ARG A 150 GLY A 217 GLY A 156	None None PO4 A 302 (-3.8A) PO4 A 302 (-3.6A)	0.88A	4koeA-4adsA: undetectable 4koeB-4adsA: undetectable 4koeC-4adsA: undetectable	4koeA-4adsA: 20.37 4koeB-4adsA: 20.37 4koeC-4adsA: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1Z_A_MXMA807_2 (PROSTAGLANDIN G/H SYNTHASE 1)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 6	VAL G 57 LEU G 11 LEU G 72 PHE G 209	None	1.12A	4o1zA-4adsG: undetectable	4o1zA-4adsG: 18.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QB9_A_PARA500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 10	PHE G 112 PHE G 110 GLU G 198 ASP G 14 GLY G 52	None	1.46A	4qb9A-4adsG: undetectable	4qb9A-4adsG: 17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QB9_E_PARE500_1 (ENHANCED INTRACELLULAR SURVIVAL PROTEIN)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 12	PHE G 112 PHE G 110 GLU G 198 ASP G 14 GLY G 52	None	1.43A	4qb9E-4adsG: undetectable	4qb9E-4adsG: 17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP4_A_COCA706_1 (DOPAMINE TRANSPORTER)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 11	VAL G 166 ASP G 116 GLY G 85 SER G 94 GLY G 114	None	1.24A	4xp4A-4adsG: undetectable	4xp4A-4adsG: 17.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XUM_B_IMNB501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	5 / 11	GLY G 89 CYH G 90 SER G 94 ILE G 117 ILE G 83	None	1.10A	4xumB-4adsG: undetectable	4xumB-4adsG: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YP2_B_NCAB302_0 (RIBOSOME-INACTIVATIN G PROTEIN MOMORDIN I)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 9	ILE A 25 PHE A 213 GLY A 234 ILE A 43 ALA A 42	None	1.01A	4yp2B-4adsA: undetectable	4yp2B-4adsA: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z53_F_TR6F101_1 (DNA TOPOISOMERASE 4 SUBUNIT B,DNA TOPOISOMERASE 4 SUBUNIT A E-SITE DNA)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 6	GLY A 217 GLY A 156 SER A 107 ARG A 150	PO4 A 302 (-3.8A) PO4 A 302 (-3.6A) None None	0.86A	4z53A-4adsA: undetectable 4z53B-4adsA: undetectable	4z53A-4adsA: 17.69 4z53B-4adsA: 17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_H_SAMH301_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 12	ALA A 219 GLY A 156 GLY A 158 GLY A 280 GLU A 108	None PO4 A 302 (-3.6A) None None None	0.93A	5c0oH-4adsA: undetectable	5c0oH-4adsA: 23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CF9_B_NCAB302_0 (RIBOSOME-INACTIVATIN G PROTEIN MOMORDIN I)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 9	ILE A 25 PHE A 213 GLY A 234 ILE A 43 ALA A 42	None	1.04A	5cf9B-4adsA: undetectable	5cf9B-4adsA: 23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0Y_A_FOLA201_0 (CONSERVED HYPOTHETICAL MEMBRANE PROTEIN)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	5 / 12	LEU A 139 GLY A 145 ASP A 105 SER A 107 HIS A 14	None	1.26A	5d0yA-4adsA: undetectable	5d0yA-4adsA: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DWK_C_ACTC207_0 (DIACYLGLYCEROL KINASE)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 5	GLU A 162 ALA A 284 GLU A 154 ASN A 159	None	1.45A	5dwkC-4adsA: undetectable	5dwkC-4adsA: 18.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJZ_A_GMJA301_1 (SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1)	4ads	PDX2 PROTEIN (Plasmodium falciparum)	4 / 6	ASP G 14 GLN G 12 GLU G 198 THR G 193	None	1.37A	6djzA-4adsG: undetectable	6djzA-4adsG: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FI4_B_DVAB8_0 (14-3-3 PROTEIN SIGMA PRO-SEP-LEU-PRO-DVA)	4ads	PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE (Plasmodium berghei)	4 / 5	SER A 271 VAL A 270 ASN A 269 PRO A 264	None	1.26A	6fi4A-4adsA: undetectable 6fi4B-4adsA: undetectable	6fi4A-4adsA: 23.41 6fi4B-4adsA: 3.14

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D4F_B_ADNB602_2","S-ADENOSYLHOMOCYSTEINE HYDROLASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"THR G  86;THR G 193;THR G 149;HIS G  21","None","1.33A","1d4fB-4adsG:3.0","1d4fB-4adsG:17.51"],["1FOH_C_IPHC802_0","PHENOL HYDROXYLASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"ASP G  45;GLY G  46;VAL G 213;ILE G   4;GLY G   7","None","1.39A","1fohC-4adsG:undetectable","1fohC-4adsG:13.81"],["1FOH_D_IPHD802_0","PHENOL HYDROXYLASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"ASP G  45;GLY G  46;VAL G 213;ILE G   4;GLY G   7","None","1.36A","1fohD-4adsG:undetectable","1fohD-4adsG:13.81"],["1L2I_A_CCSA417_0","ESTROGEN RECEPTOR","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",3,"GLU A  92;LYS A  84;VAL A  85","None","0.98A","1l2iA-4adsA:undetectable","1l2iA-4adsA:23.18"],["1MRG_A_ADNA300_1","ALPHA-MOMORCHARIN","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"ILE A  25;PHE A 213;GLY A 234;ILE A  43;ALA A  42","None","1.17A","1mrgA-4adsA:undetectable","1mrgA-4adsA:22.62"],["1PN0_B_IPHB6022_0","PHENOL 2-MONOOXYGENASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"ASP G  45;GLY G  46;VAL G 213;ILE G   4;GLY G   7","None","1.42A","1pn0B-4adsG:undetectable","1pn0B-4adsG:14.74"],["1PN0_C_IPHC6032_0","PHENOL 2-MONOOXYGENASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"ASP G  45;GLY G  46;VAL G 213;ILE G   4;GLY G   7","None","1.41A","1pn0C-4adsG:undetectable","1pn0C-4adsG:14.74"],["1PN0_D_IPHD6042_0","PHENOL 2-MONOOXYGENASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"ASP G  45;GLY G  46;VAL G 213;ILE G   4;GLY G   7","None","1.41A","1pn0D-4adsG:undetectable","1pn0D-4adsG:14.74"],["1T46_A_STIA3_2","HOMO SAPIENS V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"VAL G  97;CYH G 152;ARG G  58;CYH G  87","None","1.19A","1t46A-4adsG:undetectable","1t46A-4adsG:23.28"],["1YA4_C_CTXC3_1","CES1 PROTEIN","4ads","PDX2 PROTEIN","Plasmodium falciparum",6,"PHE G 209;GLY G  85;GLY G  89;VAL G  57;LEU G  92;LEU G  11","None","1.50A","1ya4C-4adsG:undetectable","1ya4C-4adsG:17.82"],["2AOI_C_FRDC305_1","POL POLYPROTEIN;PEPTIDE INHIBITOR","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"GLY A 136;PRO A 209;VAL A 210;ILE A 149","None","0.85A","2aoiA-4adsA:undetectable","2aoiA-4adsA:17.37"],["2UXO_B_TACB1211_1","HTH-TYPE TRANSCRIPTIONAL REGULATOR TTGR","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"LEU G  11;LEU G  68;ILE G  32;VAL G  48;ILE G  49","None","1.06A","2uxoB-4adsG:undetectable","2uxoB-4adsG:20.34"],["2ZMA_A_ACAA501_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"ALA G 183;ILE G 181;ILE G 158;TYR G 157","None","1.05A","2zmaA-4adsG:undetectable","2zmaA-4adsG:19.34"],["3CL9_A_MTXA602_1","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE (DHFR-TS)","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"ALA A 214;ILE A 160;THR A 220;LEU A 267;PRO A 264","None","1.29A","3cl9A-4adsA:undetectable","3cl9A-4adsA:20.19"],["3H5G_B_LEIB16_0","COIL SER L16D-PEN","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"LEU A 104;GLN A  94;LEU A  96;GLU A  97","None","1.05A","3h5gA-4adsA:undetectable;3h5gB-4adsA:undetectable","3h5gA-4adsA:7.89;3h5gB-4adsA:7.89"],["3MDV_A_CL6A506_1","CHOLESTEROL 24-HYDROXYLASE","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"LEU G 135;LEU G 169;ALA G 204;ALA G 184;THR G 193","None","1.13A","3mdvA-4adsG:undetectable","3mdvA-4adsG:19.95"],["3PHN_A_ACTA108_0","PROTEIN P-30","4ads","PDX2 PROTEIN","Plasmodium falciparum",3,"THR G  55;SER G  54;ARG G 121","None","0.82A","3phnA-4adsG:undetectable","3phnA-4adsG:20.64"],["4AX8_A_SAMA1474_0","WBDD","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",6,"GLY A 217;ALA A 155;ILE A 218;ILE A 160;HIS A 166;ILE A 164","PO4 A 302 (-3.8A);PO4 A 302 ( 4.1A);None;None;None;None","1.49A","4ax8A-4adsA:undetectable","4ax8A-4adsA:22.41"],["4AZV_A_SAMA1474_0","WBDD","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",6,"GLY A 217;ALA A 155;ILE A 218;ILE A 160;HIS A 166;ILE A 164","PO4 A 302 (-3.8A);PO4 A 302 ( 4.1A);None;None;None;None","1.49A","4azvA-4adsA:undetectable","4azvA-4adsA:22.41"],["4FGL_C_CLQC303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"GLY G   7;VAL G   8;PHE G  75;ILE G  83","None","0.86A","4fglD-4adsG:4.3","4fglD-4adsG:23.58"],["4FGL_D_CLQD303_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"GLY G   7;VAL G   8;PHE G  75;ILE G  83","None","0.87A","4fglC-4adsG:4.2","4fglC-4adsG:23.58"],["4HYT_A_OBNA1104_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"GLU G  16;GLY G  51;ALA G  88;LEU G  11;THR G  56","None","1.12A","4hytA-4adsG:undetectable","4hytA-4adsG:12.89"],["4HYT_C_OBNC2004_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"GLU G  16;GLY G  51;ALA G  88;LEU G  11;THR G  56","None","1.13A","4hytC-4adsG:undetectable","4hytC-4adsG:12.89"],["4KOE_F_TR6F101_1","DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B;E-SITE DNA2","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"SER A 107;ARG A 150;GLY A 217;GLY A 156","None;None;PO4 A 302 (-3.8A);PO4 A 302 (-3.6A)","0.88A","4koeA-4adsA:undetectable;4koeB-4adsA:undetectable;4koeC-4adsA:undetectable","4koeA-4adsA:20.37;4koeB-4adsA:20.37;4koeC-4adsA:22.84"],["4O1Z_A_MXMA807_2","PROSTAGLANDIN G\/H SYNTHASE 1","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"VAL G  57;LEU G  11;LEU G  72;PHE G 209","None","1.12A","4o1zA-4adsG:undetectable","4o1zA-4adsG:18.00"],["4QB9_A_PARA500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"PHE G 112;PHE G 110;GLU G 198;ASP G  14;GLY G  52","None","1.46A","4qb9A-4adsG:undetectable","4qb9A-4adsG:17.36"],["4QB9_E_PARE500_1","ENHANCED INTRACELLULAR SURVIVAL PROTEIN","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"PHE G 112;PHE G 110;GLU G 198;ASP G  14;GLY G  52","None","1.43A","4qb9E-4adsG:undetectable","4qb9E-4adsG:17.36"],["4XP4_A_COCA706_1","DOPAMINE TRANSPORTER","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"VAL G 166;ASP G 116;GLY G  85;SER G  94;GLY G 114","None","1.24A","4xp4A-4adsG:undetectable","4xp4A-4adsG:17.54"],["4XUM_B_IMNB501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4ads","PDX2 PROTEIN","Plasmodium falciparum",5,"GLY G  89;CYH G  90;SER G  94;ILE G 117;ILE G  83","None","1.10A","4xumB-4adsG:undetectable","4xumB-4adsG:21.00"],["4YP2_B_NCAB302_0","RIBOSOME-INACTIVATING PROTEIN MOMORDIN I","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"ILE A  25;PHE A 213;GLY A 234;ILE A  43;ALA A  42","None","1.01A","4yp2B-4adsA:undetectable","4yp2B-4adsA:23.23"],["4Z53_F_TR6F101_1","DNA TOPOISOMERASE 4 SUBUNIT B,DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B,DNA TOPOISOMERASE 4 SUBUNIT A;E-SITE DNA","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"GLY A 217;GLY A 156;SER A 107;ARG A 150","PO4 A 302 (-3.8A);PO4 A 302 (-3.6A);None;None","0.86A","4z53A-4adsA:undetectable;4z53B-4adsA:undetectable","4z53A-4adsA:17.69;4z53B-4adsA:17.69"],["5C0O_H_SAMH301_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"ALA A 219;GLY A 156;GLY A 158;GLY A 280;GLU A 108","None;PO4 A 302 (-3.6A);None;None;None","0.93A","5c0oH-4adsA:undetectable","5c0oH-4adsA:23.92"],["5CF9_B_NCAB302_0","RIBOSOME-INACTIVATING PROTEIN MOMORDIN I","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"ILE A  25;PHE A 213;GLY A 234;ILE A  43;ALA A  42","None","1.04A","5cf9B-4adsA:undetectable","5cf9B-4adsA:23.23"],["5D0Y_A_FOLA201_0","CONSERVED HYPOTHETICAL MEMBRANE PROTEIN","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",5,"LEU A 139;GLY A 145;ASP A 105;SER A 107;HIS A  14","None","1.26A","5d0yA-4adsA:undetectable","5d0yA-4adsA:21.63"],["5DWK_C_ACTC207_0","DIACYLGLYCEROL KINASE","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"GLU A 162;ALA A 284;GLU A 154;ASN A 159","None","1.45A","5dwkC-4adsA:undetectable","5dwkC-4adsA:18.91"],["6DJZ_A_GMJA301_1","SIGMA NON-OPIOID INTRACELLULAR RECEPTOR 1","4ads","PDX2 PROTEIN","Plasmodium falciparum",4,"ASP G  14;GLN G  12;GLU G 198;THR G 193","None","1.37A","6djzA-4adsG:undetectable","6djzA-4adsG:21.40"],["6FI4_B_DVAB8_0","14-3-3 PROTEIN SIGMA;PRO-SEP-LEU-PRO-DVA","4ads","PYRIDOXINE BIOSYNTHETIC ENZYME PDX1 HOMOLOGUE, PUTATIVE","Plasmodium berghei",4,"SER A 271;VAL A 270;ASN A 269;PRO A 264","None","1.26A","6fi4A-4adsA:undetectable;6fi4B-4adsA:undetectable","6fi4A-4adsA:23.41;6fi4B-4adsA:3.14"]]